Colorectal Cancer Crc clinical trials

Explore recruiting colorectal cancer crc clinical trials.

Recruiting colorectal cancer crc studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Colorectal Cancer Crc trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

PRODIGE 88-CIRCULATE PAC: Phase III multicentric, open-label, randomized study to investigate the efficacy of chemotherapy in patients with positive ctDNA after surgery and adjuvant chemotherapy for a high-risk stage II and stage III Colorectal Cancer

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

​​A Phase 3 Multicenter, Randomized, Openlabel, Active-controlled Study of Sotorasib and Panitumumab Versus Investigator’s Choice (Trifluridine and Tipiracil, or Regorafenib) for the Treatment of Previously Treated Metastatic Colorectal Cancer Subjects with KRAS p.G12C Mutation​

Italy, Germany, Greece, France, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase II trial of Pembrolizumab and Olaparib in homologous-recombination deficient (HRD) advanced colorectal cancer (CRC).

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

METIMMOX-2: Metastatic pMMR/MSS Colorectal Cancer – Shaping Anti-Tumor Immunity by Oxaliplatin

Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase 3 Multicenter, Randomized, Open-label, Active-controlled Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb for Treatment-naïve Subjects With Metastatic Colorectal Cancer With KRAS p.G12C Mutation (CodeBreaK 301)

Poland, Belgium, Netherlands, Austria, Hungary, Germany +12 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2, Open Label, Multicenter, Randomized Study, to Evaluate the Efficacy and Safety of Denikitug Monotherapy and Denikitug-based Combinations in Participants With Advanced Microsatellite Stable (MSS) Colorectal Cancer (CRC).

Spain, Italy, France

Therapeutic exploratory (Phase II) EU CTIS Study details

Colorectal Cancer Crc trials by city

Colorectal Cancer Crc in Toronto Colorectal Cancer Crc in Vancouver Colorectal Cancer Crc in Montreal Colorectal Cancer Crc in Calgary Colorectal Cancer Crc in Edmonton Colorectal Cancer Crc in Ottawa Colorectal Cancer Crc in Winnipeg Colorectal Cancer Crc in Quebec City Colorectal Cancer Crc in Hamilton Colorectal Cancer Crc in Kitchener Colorectal Cancer Crc in London Colorectal Cancer Crc in Halifax Colorectal Cancer Crc in New York Colorectal Cancer Crc in Los Angeles Colorectal Cancer Crc in Chicago Colorectal Cancer Crc in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease